Thomas Graham's Top Holdings: A Deep Dive into Kahn Brothers Group's Portfolio
Thomas Graham's portfolio, managed by Kahn Brothers Group, is heavily concentrated in Financial Services and Healthcare, with significant allocations to Citigroup, Bayer, and Merck.
As of December 31, 2025, the portfolio managed by Thomas Graham, representing the investment strategy of the Kahn Brothers Group, totals $564.7 million. Graham's holdings demonstrate a clear preference for sectors such as Financial Services and Healthcare, with significant allocations to companies like Citigroup, Bayer AG, and Merck & Co.
Graham's largest position is in Citigroup Inc (C), holding 18.11% of the portfolio. The investment saw a slight reduction in shares (-0.04%) during the prior period, indicating a minor adjustment in Graham's stance towards this financial services giant.
Bayer AG Spons ADR (BAYRY) represents another core holding, accounting for 12.94% of Graham's assets. Graham减持了12,940股股票，持股比例下降了0.49%，显示对这家德国制药巨头的信心略有减弱。
Flagstar Financial, Inc. (NYCB) is the third-largest holding at 9.31% allocation. Graham减持了119,540股股票，持股比例下降了2.78%， suggesting a more significant reduction in exposure to this financial institution.
Merck & Co. Inc. (MRK) holds an 8.02% allocation in Graham's portfolio. Despite a small decrease in shares (-0.84%), Graham's confidence in this pharmaceutical leader remains substantial.
Walt Disney (DIS) and Alphabet Inc Class C (GOOG) each represent 7.95% and 7.52% of the portfolio, respectively. Graham maintained his position in Disney but slightly increased Alphabet shares (+0.52%), highlighting a potential tilt towards technology search within the entertainment and tech conglomerates.
BP PLC (BP) and Seaboard Corp (SEB) round out the top eight holdings, representing 6.39% and 5.73% of Graham's investments. Graham减持了英国石油股份（-4.35%）但增持了Seaboard stock (+5.68%), despite the small position size.
The remaining top holdings include Organon & Co (OGN) at 4.61% and Idt Corp Class B (IDT) at 3.55%. Graham增持了Organon shares (+0.35%) while maintaining a small stake in Idt.
Overall, Graham's portfolio reflects a strategic focus on established players in Financial Services and Healthcare, with some exposure to consumer-facing companies like Disney and technology firms like Alphabet. The modest share changes observed across most positions suggest a generally stable, long-term investment approach.